These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Toward immunomodulatory and anti-inflammatory properties of statins. Arnaud C; Braunersreuther V; Mach F Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129 [TBL] [Abstract][Full Text] [Related]
7. The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation. Wilensky RL; Hamamdzic D Curr Opin Cardiol; 2007 Nov; 22(6):545-51. PubMed ID: 17921743 [TBL] [Abstract][Full Text] [Related]
8. Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome. Rosenson RS; Brewer HB; Rader DJ Circ Res; 2014 Jun; 114(12):1880-9. PubMed ID: 24902972 [TBL] [Abstract][Full Text] [Related]
9. Inflammation in coronary artery diseases. Li JJ Chin Med J (Engl); 2011 Nov; 124(21):3568-75. PubMed ID: 22340179 [TBL] [Abstract][Full Text] [Related]
10. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention. Chapman MJ Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923 [TBL] [Abstract][Full Text] [Related]
11. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease]. Galle J Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336 [TBL] [Abstract][Full Text] [Related]
13. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A; J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114 [TBL] [Abstract][Full Text] [Related]
14. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?]. Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606 [TBL] [Abstract][Full Text] [Related]
15. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis. Bertrand MJ; Tardif JC Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063 [TBL] [Abstract][Full Text] [Related]
16. Statins and other agents for vascular inflammation. Owens CD J Vasc Surg; 2012 Dec; 56(6):1799-806. PubMed ID: 23017371 [TBL] [Abstract][Full Text] [Related]
17. A new way of targeting to treat coronary artery disease. Siu D J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):1-6. PubMed ID: 19829140 [TBL] [Abstract][Full Text] [Related]
20. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]